Intriguing, the pharmacological manipulation of Wnt pathway, using GSK3β inhibitors (lithium chloride, SB216763) (Figure 1A), is a promising therapeutic approach for several pathologies such as diabetes, stroke, mood disorders, inflammation, and Alzheimer’s disease [135]. The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.